These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10597194)

  • 1. CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines.
    Frisan T; Donati D; Cervenak L; Wilson J; Masucci MG; Bejarano MT
    Int J Cancer; 1999 Dec; 83(6):772-9. PubMed ID: 10597194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells.
    Khanna R; Cooper L; Kienzle N; Moss DJ; Burrows SR; Khanna KK
    J Immunol; 1997 Dec; 159(12):5782-5. PubMed ID: 9550373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic reticulum signal sequence facilitated transport of peptide epitopes restores immunogenicity of an antigen processing defective tumour cell line.
    Khanna R; Burrows SR; Argaet V; Moss DJ
    Int Immunol; 1994 Apr; 6(4):639-45. PubMed ID: 7517178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV peptide epitope sensitization restores human cytotoxic T cell recognition of Burkitt's lymphoma cells. Evidence for a critical role for ICAM-2.
    Khanna R; Burrows SR; Suhrbier A; Jacob CA; Griffin H; Misko IS; Sculley TB; Rowe M; Rickinson AB; Moss DJ
    J Immunol; 1993 Jun; 150(11):5154-62. PubMed ID: 7684421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective induction of allostimulatory capacity after 5-azaC treatment of EBV carrying but not EBV negative Burkitt lymphoma cell lines.
    Cuomo L; Trivedi P; de Campos-Lima PO; Zhang QJ; Ragnar E; Klein G; Masucci MG
    Mol Immunol; 1993 Apr; 30(5):441-50. PubMed ID: 7681932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective presentation of MHC class I-restricted cytotoxic T-cell epitopes in Burkitt's lymphoma cells.
    Frisan T; Zhang QJ; Levitskaya J; Coram M; Kurilla MG; Masucci MG
    Int J Cancer; 1996 Oct; 68(2):251-8. PubMed ID: 8900437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential involvement of CD40, CD80, and major histocompatibility complex class I molecules in cytotoxicity induction and interferon-gamma production by human natural killer effectors.
    Terrazzano G; Zanzi D; Palomba C; Carbone E; Grimaldi S; Pisanti S; Fontana S; Zappacosta S; Ruggiero G
    J Leukoc Biol; 2002 Aug; 72(2):305-11. PubMed ID: 12149421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance.
    Gregory CD; Murray RJ; Edwards CF; Rickinson AB
    J Exp Med; 1988 Jun; 167(6):1811-24. PubMed ID: 2898508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
    Singal DP; Ye M; Ni J; Snider DP
    Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
    Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
    J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of class I HLA antigens and of the Epstein-Barr virus-encoded latent membrane protein in Burkitt lymphoma lines.
    Masucci MG; Torsteindottir S; Colombani J; Brautbar C; Klein E; Klein G
    Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4567-71. PubMed ID: 3037521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Class I processing-defective Burkitt's lymphoma cells are recognized efficiently by CD4+ EBV-specific CTLs.
    Khanna R; Burrows SR; Thomson SA; Moss DJ; Cresswell P; Poulsen LM; Cooper L
    J Immunol; 1997 Apr; 158(8):3619-25. PubMed ID: 9103423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell phenotype dependent expression of MHC class I antigens in Burkitt's lymphoma cell lines.
    Masucci MG; Klein E
    Semin Cancer Biol; 1991 Feb; 2(1):63-71. PubMed ID: 1655115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10.
    Zeidler R; Eissner G; Meissner P; Uebel S; Tampé R; Lazis S; Hammerschmidt W
    Blood; 1997 Sep; 90(6):2390-7. PubMed ID: 9310490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
    Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A synthetic peptide homologous to functional domain of human IL-10 down-regulates expression of MHC class I and Transporter associated with Antigen Processing 1/2 in human melanoma cells.
    Kurte M; López M; Aguirre A; Escobar A; Aguillón JC; Charo J; Larsen CG; Kiessling R; Salazar-Onfray F
    J Immunol; 2004 Aug; 173(3):1731-7. PubMed ID: 15265902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to natural killer cell lysis conferred by TAP1/2 genes in human antigen-processing mutant cells.
    Salcedo M; Momburg F; Hämmerling GJ; Ljunggren HG
    J Immunol; 1994 Feb; 152(4):1702-8. PubMed ID: 8120379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.